Inactive Instrument

News Redx Pharma Plc London S.E.

Equities

Redx Reports Encouraging Zamaporvint (RXC004) Phase 2 Combination Data in MSS mCRC at ESMO GI Congress Supporting Genetic Selection Hypothesis in Hard-to-Treat GI Cancers	Jun. 28	EQ
Redx Pharma Plc Reports Encouraging Zamaporvint Phase 2 Combination Data in MSS mCRC at ESMO GI Congress	Jun. 28	CI
Redx to Present Zamaporvint Phase2 Data At Esmo Gi	Jun. 20	CI
Redx to Present Preclinical Data on RXC008 in an Oral Presentation at ECM Congress	Jun. 17	CI
Redx Pharma : to Present Preclinical Data on RXC008 in an Oral Presentation at ECM Congress	Jun. 14	PU
Redx Pharma plc Appoints Claire Catherinet as Director	May. 15	CI
Redx Pharma plc Announces the Termination of Dr Joseph Anderson as Director	May. 14	CI
Redx Pharma : Confirms Changes to Board Composition	May. 14	PU

No results for this search